CCP
ELV icon

Cassia Capital Partners’s Elevance Health ELV Stock Holding History

Cassia Capital Partners’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-613
Closed -$282K – 66
2023
Q1 		$282K Sell
613
-38
-6% -$18.1K 0.23% 52
2022
Q4 		$334K Buy
+651
New +$331K 0.27% 39
2021
Q4 		– Sell
-650
Closed -$242K – 93
2021
Q3 		$242K Buy
+650
New +$247K 0.17% 91

Other funds holding ELV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Sanders Capital
Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Cassia Capital Partners's ELV Position: Q2 2023 in Review

Cassia Capital Partners sold out of Elevance Health (ELV) in Q2 2023, closing a stake of 613 shares — an estimated $282K sold.

Cassia Capital Partners first reported a position in ELV in Q3 2021 and held it in 3 quarters. The position peaked at $334K in Q4 2022. 1,523 funds tracked by Wall St. Rank hold ELV as of Q2 2023.

  • Cassia Capital Partners reported no remaining Elevance Health position as of Q2 2023 after selling out during the quarter.
  • Cassia Capital Partners sold 613 Elevance Health shares in Q2 2023, an estimated $282K.
  • Cassia Capital Partners first reported a position in Elevance Health in Q3 2021 and held it in 3 quarters.
  • Cassia Capital Partners's Elevance Health position peaked at $334K in Q4 2022.
  • 1,523 funds tracked by Wall St. Rank held Elevance Health as of Q2 2023.

Based on Cassia Capital Partners's 13F filing for Q2 2023, filed 20 Jul 2023.